<DOC>
	<DOCNO>NCT01928498</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness paclitaxel-coated balloon catheter prevent restenosis PTA ( percutaneous transluminal angioplasty ) hemodialysis access ( HA ) comparison uncoated PTA balloon catheter .</brief_summary>
	<brief_title>Drug Eluting Balloon Prevention Hemodialysis Access Restenosis</brief_title>
	<detailed_description>In Canada , 20,000 patient chronic end-stage renal disease ( ESRD ) long-term hemodialysis number increase rapidly.The creation hemodialysis access ( HA ) ( also call `` lifeline '' dialysis patient ) become common type vascular surgery . These HA frequently complicate dysfunction creation mainly due neointimal hyperplastic stenosis ( &gt; 60 % one year ) . PTA establish cornerstone method treat stenotic lesion minimally invasive percutaneous nature widespread availability.Although PTA high initial success rate , narrow often recur 2-3 month hence require intervention . There currently durable therapy prevention treatment HA dysfunction restenosis PTA . Recently drug elute balloon ( DEB ) paclitaxel repeatedly demonstrate effectiveness prevent restenosis due intimal proliferation coronary peripheral arterial system . The investigator believe DEB paclitaxel significantly decrease HA restenosis rate treat site therefore improve management HA failure .</detailed_description>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Clinical hemodynamic evidence HA dysfunction accord clinician 's judgment Patients AVF ( arteriovenous fistula ) AVG ( arteriovenous graft ) locate forearm upper arm &gt; 3 month old Minimum age 18 year write informed consent Target lesion stenosis &lt; 3.0 cm length &gt; 50 % luminal diameter reduction Maximum two secondary lesion ( stenosis ) follow criterion satisfy : The secondary lesion locate graft peripheral vein , secondary lesion &lt; 3.0 cm length locate &gt; 1.0 cm away target lesion , secondary lesion &gt; 50 % luminal reduction compare reference vessel diameter Reference vessel diameter 4 7 mm The HA must thrombose lesion cross guide wire angioplasty Lesion site : 2 cm arterial anastomosis superior vena cava Restenotic lesion ( previously treat PTA stent ) de novo lesion Contraindication angiography PTA Intervention HA circuit within past 30 day Systemic infection local infection associate graft The patient pregnant Patient enrol another investigational study . Life expectancy &lt; 12 month History severe allergic reaction contrast medium paclitaxel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>arteriovenous fistula</keyword>
	<keyword>arteriovenous graft</keyword>
	<keyword>restenosis</keyword>
	<keyword>angioplasty</keyword>
	<keyword>drug elute balloon</keyword>
</DOC>